Cytodyn Inc (CYDY)

[DonDonDonDon]

82% reduction in mortality at 14 days. P=0.023.

What part of 82% is nothing?!

It is a small trial. And you are looking at a 16% slice of a small trial. 62 patients. There is a benefit at 14 days but not much benefit at 28 days. What matters is 28 days, not 14 days.

I think it is smart that CytoDyn is going with the theory that most of the efficacy was lost because patients didn't get dosed after day 8. Makes sense to me to give it to the patient as long as they are hospitalized even if that is 12 weeks. Seems really shortsighted and/or cheap to not have given more than 2 doses in the original trial. Kind of cruel to cut off the patient from access if it was working. Both the patient and trial would have benefitted from continued doses.